135 related articles for article (PubMed ID: 25880407)
21. Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling.
Güder G; Störk S; Gelbrich G; Brenner S; Deubner N; Morbach C; Wallenborn J; Berliner D; Ertl G; Angermann CE
Eur J Heart Fail; 2015 Apr; 17(4):442-52. PubMed ID: 25727879
[TBL] [Abstract][Full Text] [Related]
22. Prognostic benefit of beta-blockers in patients not receiving ACE-Inhibitors.
Krum H; Haas SJ; Eichhorn E; Ghali J; Gilbert E; Lechat P; Packer M; Roecker E; Verkenne P; Wedel H; Wikstrand J
Eur Heart J; 2005 Oct; 26(20):2154-8. PubMed ID: 16014644
[TBL] [Abstract][Full Text] [Related]
23. [Is heart rate adequately controlled in chronic systolic heart failure patients in Germany? results from a nationwide survey (INDICATE)].
Zugck C; Martinka P; Stöckl G; Tschöpe C; Störk S
Dtsch Med Wochenschr; 2015 Mar; 140(5):e48-55. PubMed ID: 25734683
[TBL] [Abstract][Full Text] [Related]
24. Prescription in patients with chronic heart failure and multimorbidity attended in primary care.
Frigola-Capell E; Verdú-Rotellar JM; Comin-Colet J; Davins-Miralles J; Hermosilla E; Wensing M; Suñol R
Qual Prim Care; 2013; 21(4):211-9. PubMed ID: 24041138
[TBL] [Abstract][Full Text] [Related]
25. Comparison of late mortality in hospitalized patients >70 years of age with systolic heart failure receiving beta blockers versus those not receiving beta blockers.
Pascual-Figal DA; Redondo B; Caro C; Manzano S; Garrido IP; Ruipérez JA; Valdés M
Am J Cardiol; 2008 Dec; 102(12):1711-7. PubMed ID: 19064029
[TBL] [Abstract][Full Text] [Related]
26. Improved guideline adherence to pharmacotherapy of chronic systolic heart failure in general practice--results from a cluster-randomized controlled trial of implementation of a clinical practice guideline.
Peters-Klimm F; Müller-Tasch T; Remppis A; Szecsenyi J; Schellberg D
J Eval Clin Pract; 2008 Oct; 14(5):823-9. PubMed ID: 19018915
[TBL] [Abstract][Full Text] [Related]
27. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis.
Cheng J; Zhang W; Zhang X; Han F; Li X; He X; Li Q; Chen J
JAMA Intern Med; 2014 May; 174(5):773-85. PubMed ID: 24687000
[TBL] [Abstract][Full Text] [Related]
28. Adherence to the guidelines on the management of systolic heart failure in ambulatory care in Poland. Data from the international QUALIFY survey.
Opolski G; Ozierański K; Lelonek M; Balsam P; Wilkins A; Ponikowski P; On Behalf Of The Polish Qualify Investigators
Pol Arch Intern Med; 2017 Oct; 127(10):657-665. PubMed ID: 28786405
[TBL] [Abstract][Full Text] [Related]
29. Critical evaluation of the optimal medical therapy in the cardiac resynchronization therapy candidates--single centre experience.
Vondráková D; Málek F; Dvorák J; Sedivá L; Kupec J; Petrů J; Táborský M; Neuzil P
Vnitr Lek; 2011 Oct; 57(10):799-802. PubMed ID: 22097686
[TBL] [Abstract][Full Text] [Related]
30. Nurse-Led Titration of Angiotensin-Converting Enzyme Inhibitors, β-Adrenergic Blocking Agents, and Angiotensin Receptor Blockers in Patients With Heart Failure With Reduced Ejection Fraction.
Driscoll A; Currey J; Tonkin AM
JAMA Cardiol; 2016 Oct; 1(7):842-843. PubMed ID: 27556747
[TBL] [Abstract][Full Text] [Related]
31. Clinical characteristics and long-term prognosis in patients with chronic heart failure and reduced ejection fraction in China.
Liu X; Yu H; Pei J; Chu J; Pu J; Zhang S
Heart Lung Circ; 2014 Sep; 23(9):818-26. PubMed ID: 24881031
[TBL] [Abstract][Full Text] [Related]
32. Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: a meta-analysis of > 35,000 patients.
Peck KY; Lim YZ; Hopper I; Krum H
Int J Cardiol; 2014 May; 173(2):197-203. PubMed ID: 24636548
[TBL] [Abstract][Full Text] [Related]
33. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis.
Verdecchia P; Angeli F; Cavallini C; Gattobigio R; Gentile G; Staessen JA; Reboldi G
Eur Heart J; 2009 Mar; 30(6):679-88. PubMed ID: 19168534
[TBL] [Abstract][Full Text] [Related]
34. Relationship between beta-blocker and angiotensin-converting enzyme inhibitor dose and clinical outcome following acute myocardial infarction.
Grall S; Biere L; Le Nezet M; Bouvier JM; Lucas-Chauvelon P; Richard C; Abi-Khalil W; Delepine S; Prunier F; Furber A
Circ J; 2015; 79(3):632-40. PubMed ID: 25746548
[TBL] [Abstract][Full Text] [Related]
35. Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure: Results From BIOSTAT-CHF.
Ouwerkerk W; Zwinderman AH; Ng LL; Demissei B; Hillege HL; Zannad F; van Veldhuisen DJ; Samani NJ; Ponikowski P; Metra M; Ter Maaten JM; Lang CC; van der Harst P; Filippatos G; Dickstein K; Cleland JG; Anker SD; Voors AA
J Am Coll Cardiol; 2018 Jan; 71(4):386-398. PubMed ID: 29389354
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of a Pharmacist-Managed Heart Failure Medication Titration Assistance Clinic.
Bhat S; Kansal M; Kondos GT; Groo V
Ann Pharmacother; 2018 Aug; 52(8):724-732. PubMed ID: 29463107
[TBL] [Abstract][Full Text] [Related]
37. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
Fabbri G; Gorini M; Maggioni AP; Di Lenarda A;
G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354
[TBL] [Abstract][Full Text] [Related]
38. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B
Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155
[TBL] [Abstract][Full Text] [Related]
39. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
Shah R; Wang Y; Foody JM
Am J Cardiol; 2008 Jan; 101(2):217-22. PubMed ID: 18178410
[TBL] [Abstract][Full Text] [Related]
40. Patient adherence to evidence-based pharmacotherapy in systolic heart failure and the transition of follow-up from specialized heart failure outpatient clinics to primary care.
Gjesing A; Schou M; Torp-Pedersen C; Køber L; Gustafsson F; Hildebrandt P; Videbæk L; Wiggers H; Demant M; Charlot M; Gislason GH
Eur J Heart Fail; 2013 Jun; 15(6):671-8. PubMed ID: 23397577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
